ClinicalTrials.gg
Status unknownNCT04228159Updated Jan 14, 2020

Perturbation Training Compared to Balance and Strengthening Exercise, for Elderly at Risk of Falling

An interventional study of Balance Tutor Biofeedback Rehabilitation System and Balance and strengthening exercise in Fall Prevention, sponsored by Clalit Health Services. Status unknown at 3 sites in Israel. Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2020-01-14.

Sponsored by Clalit Health Services · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2019), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

One third of adults over 65 and 50% of adults above 80 years old fall at list once a year. In some cases, falls result in fractures, hospitalization, functional limitations, depression, morbidity and mortality. Strong evidence support exercise training programs for fall prevention, while several studies examined the effect of perturbation training on risk of fall. The aim of this study is to evaluate the effectiveness of a perturbation training program with unexpected perturbation using balance tutor on falls and injuries among elderly at risk of falling, compared to balance and strengthening exercise.

02

Conditions studied

  • Fall Prevention

Keywords

  • Accidental Falls, Frail Elderly, Physical Therapy Specialty
03

In context

Lead sponsor

Clalit Health Services is the lead sponsor of 44 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:at least one fall during the last 12 months; age 65-85; score 24 and above allowing cognitive ability to understand simple instructions ; Time Up and Go (TUG), assessing balance, walking ability and fall risk, scored 13 and above ; ability to read Hebrew or Arabic; and the ability to walk independently 10 meters.

-

Exclusion Criteria:progressive neurological conditions (Parkinson, Multiple sclerosis, CVA); severe orthopedic conditions including lower limb or spine fractures and surgeries in the past 12 months prior to baseline; blindness; Arrhythmia; uncontrolled chronic disease (i.e., hypertension, diabetes, ischemic heart disease); diagnosed severe osteoporosis with a history of fracture during the past 3 years prior to baseline; active cancer during the past three years prior to baseline; lack of availability in the coming two months for completing the treatment protocol

-

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Perturbation training

    Session1 - baseline assessment (detailed above) Session2 - 13 - each session will begin with reassessment and documentation of balance tutor parameters for each participant as were calibrated at the end of previous session. After reassessment the training program will include: * Warm up - walking without perturbation. * Perturbation during standing position. * Perturbation during walking. * Perturbation during tandem position. * Perturbation with vestibular stimulation. * Rest according to patient needs The relative duration of each component, as well as intensity and frequency of perturbations, will be adjusted to each individual according to his ability, reassessment parameters and progression. Session14 - full reassessment of all baseline examinations including: Mini-BESTest, ABC scale, PASE, and number of falls.

    Device: Balance Tutor Biofeedback Rehabilitation System

  • Active comparator
    Balance and strengthening exercise

    Session1 - baseline assessment (detailed above). Session2 - 13 - each session will include: * Warm up (free walking or cycling). * Static balance exercise - standing position. Exercise will be performed using different bases of support (narrow, tandem, and one leg stance), eyes open/closed, unstable surfaces, functional and cognitive dual task, and vestibular stimulation. * Dynamic balance exercise - walking position. Exercise will be performed using different bases of support (narrow, tandem, and one leg stance), eyes open/closed, unstable surfaces, functional and cognitive dual task, and vestibular stimulation. * Strengthening exercise - general strengthening, particularly for lower limb. * Cool down. Level of difficulty and duration of each component will be adjusted to each individual according to his ability and progression. Session14 - full reassessment of all baseline examinations including: Mini-BESTest, ABC scale, PASE, and number of falls.

    Other: Balance and strengthening exercise

Interventions

  • DeviceBalance Tutor Biofeedback Rehabilitation System

    Balance Tutor system is a unique technology which allows for several postural control ability assessments as well as reactive response training in both standing and walking using controlled perturbation in simple task or multitask performance. Together with proactive training the system allows for optimal rehabilitation outcome and recovery

  • OtherBalance and strengthening exercise

    exercise training programs for fall prevention including walking and balance exercises, functional tasks, strength, flexibility and endurance

06

What researchers measure

Primary outcomes

  1. rate of falls and fallers

    Time frame: falls and fallers rates during 12-months following end of treatment

  2. hip fractures and hospitalizations rates due to falls

    Time frame: hip fractures and hospitalizations rates due to falls during12-months following end of treatment

Secondary outcomes

  1. Mini-BESTest

    Balance assessment according to Balance Evaluation Systems Test. The Mini-BESTest is a 14 item test scored on a 3-level ordinal scale. The total score is 28 while a lower score indicates severe balance impairment

    Time frame: end of treatment-last visit in physical therapy clinic

  2. Activities-Specific Balance Confidence Scale (ABC scale)

    The ABC scale is a 16-item self-report measure in which patients rate their balance confidence for performing activities. Items are rated on a rating scale that ranges from 0-100; 0 represents "no confidence" and 10 represents "complete confidence".

    Time frame: 12 months after end of treatment

  3. Physical Activity Scale for the Elderly (PASE)

    The PASE measures the level of self-reported physical activity in individuals aged 65 years or older and is comprised of items regarding occupational, household, and leisure activities during the previous 7-days period

    Time frame: 12 months after end of treatment

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04228159
Lead sponsor
Clalit Health Services
Collaborators
MediTouch Ltd.
Responsible party
Sponsor
First posted
Jan 14, 2020
Start date
Nov 25, 2019
Primary completion
May 25, 2021 (estimated)
Completion
May 25, 2022 (estimated)
Last update
Jan 14, 2020

Study contacts

Anat Shashua, PhD
Contact
Anatsh6@clalit.org.il
972-50-8803223
Igal Levran, MHA BPT
Contact
ilevran@clalit.org.il
972-50-6262223
Shlomit Yaron, MD
principal investigator · Clalit Health Services

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion